Abstract
Electrical cardioversion (ECV), a mainstay in atrial fibrillation (AF) treatment, is unsuccessful in up to 10–20% of patients. An important aspect of the remodeling process caused by AF is the constitutive activition of the atrium-specific acetylcholine-dependent potassium current (IK,ACh → IK,ACh-c), which is associated with ECV failure. This study investigated the role of IK,ACh-c in ECV failure and setting the atrial defibrillation threshold (aDFT) in optically mapped neonatal rat cardiomyocyte monolayers. AF was induced by burst pacing followed by application of biphasic shocks of 25–100 V to determine aDFT. Blocking IK,ACh-c by tertiapin significantly decreased DFT, which correlated with a significant increase in wavelength during reentry. Genetic knockdown experiments, using lentiviral vectors encoding a Kcnj5-specific shRNA to modulate IK,ACh-c, yielded similar results. Mechanistically, failed ECV was attributed to incomplete phase singularity (PS) removal or reemergence of PSs (i.e. re-initiation) through unidirectional propagation of shock-induced action potentials. Re-initiation occurred at significantly higher voltages than incomplete PS-removal and was inhibited by IK,ACh-c blockade. Whole-heart mapping confirmed our findings showing a 60% increase in ECV success rate after IK,ACh-c blockade. This study provides new mechanistic insight into failing ECV of AF and identifies IK,ACh-c as possible atrium-specific target to increase ECV effectiveness, while decreasing its harmfulness.
Similar content being viewed by others
Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia in humans1. Over time, AF usually progresses from paroxysmal, to persistent and finally to permanent AF, partly due to the effect of AF on the arrhythmogenic substrate and/or progression of underlying structural heart disease2,3. While short self-terminating episodes of AF may remain asymptomatic, the occurrence of longer episodes is associated with morbidity and mortality2,4,5,6. Hence, it is important to quickly convert AF to sinus rhythm in order to ameliorate symptoms and to prevent complications, but also to reduce AF-induced atrial remodeling leading to further AF progression. Consequently, termination of AF by electrical cardioversion (ECV) remains the mainstay of acute AF treatment7,8.
While progression of AF increases the need for ECV, it is also an independent predictor of ECV failure9,10. ECV may fail to convert AF to sinus rhythm in as much as 10–20% of patients, although the rate of success also depends on the energy applied9,11. However, perpetually increasing the energy of ECV in case of failure is undesirable, as this is associated with a progressive tendency for adverse events12,13. To improve acute AF treatment it is essential to increase the effectiveness of ECV and decrease the energy required for successful cardioversion, i.e. the atrial defibrillation threshold (aDFT).
A major aspect of the electrophysiological remodeling process associated with AF progression is the shortening of repolarization caused by (among other factors such as decreased L-type calcium current and increased inward rectifier potassium current) constitutive activity of the acetylcholine-dependent potassium current (IK,ACh → IK,ACh-c)14,15,16,17. Remodeling of IK,ACh-c may therefore play a pivotal role in the diminishing success of ECV with AF progression. IK,ACh is mediated by the Kir3.x family of potassium channels, which are expressed in the atria, but not in the ventricles18. As anti-arrhythmic drugs targeting ion channels shared between atria and ventricles have been shown to increase the burden of ventricular arrhythmias19,20, modulation of IK,ACh-c (as a consequence of its atrial specificity) might provide the advantage of decreasing aDFT without risking alteration of ventricular electrophysiology. However, whether IK,ACh-c affects the ECV success rate and, if so, by which mechanism, remains to be elucidated. Therefore the effects of IK,ACh-c on ECV success rate in a 2D model of reentrant atrial tachyarrhythmias were investigated. Complementary experiments were performed in a whole-heart AF model. Selective inhibition of Kir3.x activity was accomplished using tertiapin or by lentiviral vector (LV)-mediated RNA interference (RNAi).
Results
IK,ACh-c blockade decreases aDFT
To test the hypothesis that IK,ACh-c affects the atrial defibrillation success rate or the aDFT, fibrillating atrial cardiomyocyte (aCMC) cultures were treated with tertiapin (a blocker of IK,ACh-c) before being subjected to electric shocks of 25–100 V in order to determine the DFT. Tertiapin treatment notably increased the success rate of defibrillation compared to untreated controls (from 36.3 to 80.0% at 50 V and from 91.0 to 100.0% at 100 V, Fig. 1d). The increase in success rate was accompanied by a significant decrease in DFT from 60.0 ± 25.1 V in control aCMC cultures (n = 33) to 35.5 ± 10.9 V in tertiapin-treated aCMC cultures (n = 10; p < 0.05) (Fig. 1e).
IK,ACh-c blockade decreases aDFT by increasing wavelength
To elucidate the mechanisms by which IK,ACh-c blockade decreased the DFT, we first investigated the effects of tertiapin on several electrophysiological parameters (i.e. conduction velocity [CV], action potential [AP] duration at 80% repolarization [APD80], wavelength, reentry cycle length and complexity). Tertiapin (n = 10) significantly increased APD80 in aCMCs during reentry (54.0 ± 20.7 vs 25.8 ± 4.6 ms in control cultures [n = 33]) (Supplemental Fig. 2A,B), in the absence of acetylcholine, confirming the presence of constitutively active IK,ACh in the aCMC cultures18. The CV during reentry was not significantly affected (9.5 ± 2.8 vs 11.7 ± 2.9 cm/s in control cultures) (Supplemental Fig. 2A,C). Hence, the wavelength (determined by the product of APD and CV) was significantly increased by tertiapin treatment (0.48 ± 0.15 vs 0.30 ± 0.10 cm in control cultures) (Supplemental Fig. 2A,D). Through this increase in wavelength, IK,ACh-c blockade both caused a significant increase in reentry cycle length (106.2 ± 28.5 vs 61.9 ± 18.1 ms in control cultures) (Supplemental Fig. 2A,E) and decrease in arrhythmia complexity (2.5 ± 3.5 vs 5.06 ± 5.06 PSs in control cultures) (Supplemental Fig. 2A,F).
Subsequently, DFT was plotted as a function of CV, APD80, wavelength, reentry cycle length or complexity. As shown in Supplemental Fig. 3A, CV did not show any apparent relationship with DFT (R2 = 0.12). Furthermore, both reentry cycle length and APD80 displayed a weak inverse (hyperbolic-like) relationship with DFT (R2 = 0.24 and 0.34, respectively) (Supplemental Fig. 3B,C). DFT seemed to increase concordantly with the complexity of the arrhythmia, although this correlation was not very strong (R2 = 0.51, Supplemental Fig. 3D). In contrast, a more apparent relationship was found between wavelength and DFT, which showed an increase in DFT with decreasing wavelengths (R2 = 0.65, Supplemental Fig. 3E). Together, these results suggest that a blockade of IK,ACh-c decreases DFT through the resulting increase of the wavelength during reentrant tachyarrhythmias.
Effect of Kcnj5 knockdown on electrophysiological parameters and aDFT
To exclude the possibility that the DFT-lowering effect of tertiapin was caused by another mode of action than by its ability to block IK,ACh-c, Kcnj5 expression in aCMC cultures was specifically downregulated by RNAi using LV.Kir3.4↓. After transduction with LV.Kir3.4↓, Kir3.4 levels decreased to 36.5 ± 3.6% of those in LV.PpLuc↓-transduced control cultures), as judged by Western blot analyses (Fig. 1f). Optical mapping of these cultures during reentry yielded similar results as obtained following tertiapin treatment, being a significant increase in APD80 (Supplemental Fig. 4A,B), a non-significant decrease in CV (Supplemental Fig. 4A,C) and a significant increase in wavelength (Supplemental Fig. 4A,D) and reentry cycle length (Supplemental Fig. 4A,E), while arrhythmia complexity significantly decreased (Supplemental Fig. 4A,F). Importantly, also the DFT was significantly decreased by Kcnj5 knockdown (25.0 ± 3.5 [n = 14] vs 50.7 ± 19.4 V in LV.PpLuc↓-transduced cultures [n = 13]) (Fig. 1g). Trends in the relationship between aDFT and CV, APD80, wavelength, reentry cycle length or complexity were similar to those found in the tertiapin experiments described in Supplemental Fig. 3 (data not shown).
Successful defibrillation depends on forced PS removal
To investigate how an increase in wavelength by IK,ACh-c blockade or Kcnj5 knockdown decreases aDFT, mechanisms of successful and failed defibrillation were studied.
During reentry, a continuous spatial progression of activation and phase around a PS (the point surrounded by a complete cycle of phase [2π])21 (Fig. 2a,b, left pictures) was observed, perpetuating both the PS and its consequent reentrant tachyarrhythmia. Following exposure of such a culture to a high-energy electric shock, this continuous spatial progression of activation was disturbed, through simultaneous depolarization of large areas of the culture (Fig. 2a, right picture; Fig. 2c, red arrow). As a consequence, the electrical shock forced all cells to the same phase of the AP (Fig. 2b, middle picture; Fig. 2d, red and green arrow), breaking the 2π phase convergence necessary for PS maintenance. Hence, after synchronous repolarization (Fig. 2b, right picture; Fig. 2c) reentry was fully terminated (Supplemental Movie 1).
Concordantly, following exposure of a culture to a shock below the DFT, termination of the arrhythmia failed as a consequence of incomplete synchronization of phases around a PS preventing its definitive removal. In these cases, the electrical shock still elicited simultaneous activation of large areas of the cultures (Fig. 3a,c), perturbing the continuous spatial (Fig. 3a,b) and temporal (Fig. 3d) progression of activation and phase around the PS. However, tracking of the spatial and temporal phase progression showed incomplete synchronization of phase (point B in Fig. 3b,d) after the low-energy shock, causing PS persistence and failure of defibrillation (Supplemental Movie 2).
Failed defibrillation caused by post-shock formation of PSs
Interestingly, application of electrical shocks to aCMC cultures during fibrillation at voltages that eliminated all PSs present prior to the shock did not necessarily lead to successful defibrillation. In such instances, the gradual spatial progression of activation and phase present prior to shock (Fig. 4a,b, left pictures) was again interrupted by simultaneous activation of large areas of the culture, leading to phase synchronization and elimination of the existing PSs (Fig. 4b, middle picture; Fig. 4c,d, green arrows and Fig. 5a). However, if the shock strength was below DFT, new PSs formed in the culture prior to its full repolarization. The newly formed PSs again gave rise to reentrant activation, reestablishing fibrillation in a different activation pattern (re-initiation), causing a failed defibrillation attempt (Fig. 4a,b, right pictures; Fig. 4c,d; Supplemental Movie 3).
Importantly, failure of defibrillation as a consequence of re-initiation was found to occur at significantly higher voltages (e.g. closer to the DFT) than failure of defibrillation caused by failed PS removal (58.6 ± 21.6 vs 34.5 ± 8.2 V) (Fig. 5b). This indicates that of the mechanisms responsible for failed defibrillation, re-initiation is more important in setting the DFT. Together these results suggest that an increase in wavelength by IK,ACh-c blockade might decrease DFT by suppressing the occurrence of post-shock PS formation.
Mechanism of post-shock re-initiation
To elucidate the mechanism underlying post-shock formation of PSs ,we first subjected control atrial cultures (n = 10) to 25–100 V shocks without prior induction of reentry or electrical stimulation. In none of these cultures post-shock emergence of PSs was observed (Supplemental Fig. 5A,B), ruling out the shock protocol or configuration as a cause of post-shock re-initiation of reentry.
Next, we studied the repolarization of fibrillating control or tertiapin-treated cultures after applying shocks with a magnitude below the DFT established for control conditions (i.e. 30 V). This showed that the position of newly formed PSs co-localized with the steepest gradients in APD after the shock, with the post-shock reentrant wavefront moving from the area of latest towards to area of earliest repolarization (Fig. 6a). Dispersion in duration of the shock-induced AP was found to be significantly higher at the shortest pre-shock peak-to-post-shock peak intervals (PPIs) (Fig. 6b,d). IK,ACh-c blockade by tertiapin, did not prevent dispersion in repolarization of such shock-induced APs (Fig. 6c,d). In fact, post-shock APD dispersion in the tertiapin-treated cultures was significantly higher at diastolic intervals from 18–42 ms (Fig. 7d). Still, the maximal post-shock APD dispersion (i.e. at the shortest diastolic interval) did not significantly differ between control and tertiapin-treated cultures. Therefore, to actively assess the contribution of APD dispersion to re-initiation, we created permanent repolarization heterogeneities in aCMC cultures, by transducing the left half of the cultures with LV.Kir3.4↓ (or LV.PpLuc↓ as control), while leaving the right half of the cultures untransduced as described in the Supplemental Material online (Supplemental Figs 6, 7). Interestingly, such spatially-defined downregulation of Kir3.4 significantly lowered the defibrillation threshold (29.2 ± 4.6 vs 41.1 ± 13.5 V in heterogeneously PpLuc↓-transduced control cultures) (Supplemental Fig. 7F). Moreover, analysis of the area of first activation after applying shocks below the DFT showed that these sites were only found in the untransduced part (area I) of LV.Kir3.4↓-transduced aCMC cultures (n = 10) (Supplemental Fig. 7G). In comparison, in LV.PpLuc↓-treated cultures, no clear preference in re-initiation site was found, i.e. 40% of the first post-shock APs originated in the untransduced area (area I) vs 10% and 20% in the border area (area II) and transduced area (area III), respectively; n = 10) (Supplemental Fig. 7G). Together these results suggest that re-initiation and prevention of re-initiation by IK,ACh-c inhibition are not driven by repolarization heterogeneities in our model.
Subsequently, to actively assess the role of shock-induced depolarization in re-initiation, we quantified the effect of the PPI on the amplitude of the shock-induced APs at 30 V (i.e. below the average DFT) and at 90 V (i.e. above the average DFT) during fibrillation. Shock-induced AP amplitudes were significantly higher at 90 V than at 30 V (Supplemental Fig. 8A). The shock-induced AP amplitude diminished significantly with decreasing PPIs at both voltages (Supplemental Fig. 8A). Interestingly, 90-V shocks flattened the curve of the relationship between PPI and amplitude in comparison to 30-V shocks (n = 6 cultures per group), attributable to its increased effect on relative refractory tissue at short PPIs. Concordantly, in the absence of reentry or prior to electrical stimulation there was no difference in the AP amplitude induced by a 30 or 90 V shock (Supplemental Fig. 8B, n = 6 cultures per group), while the functional core of the reentrant spiral waves did not affect shock-induced depolarization (as judged by the effect of distance to the PS on the local shock-induced AP amplitude, Supplemental Fig. 8C, n = 6 cultures per group).
Importantly, the areas of PS emergence after the electrical shock also co-localized with the (borders of) areas of lowest shock-induced AP amplitude (i.e. at the areas with the shortest PPIs) (Fig. 7a), with conduction of the shock-induced AP wavefront directed from highly depolarized towards the incompletely depolarized regions (Fig. 7a,d). Tertiapin did not significantly affect the shock-induced AP amplitude (Fig. 7c). However, similar to high voltage shocks, tertiapin treatment showed a trend to flatten the curve of the relationship between PPI and shock-induced AP amplitude (Fig. 7c). Moreover, at areas of heterogeneous shock-induced depolarization in tertiapin-treated cultures, the shock-induced AP wavefront blocked on the refractory tail of the pre-shock activation, as a consequence of the tertiapin-dependent increase in wavelength (Fig. 7e).
Taken together, these results suggest that failed defibrillation through re-initiation is caused by heterogeneous depolarization as a consequence of impaired tissue depolarization at short PPIs. This causes steep post-shock membrane potential gradients, which allow unidirectional propagation of the shock-induced AP in these critical areas. IK,ACh-c blockade blunts the heterogeneity in depolarization induced by low-voltage shocks and inhibits the unidirectional propagation of shock-induced APs by increasing wavelength, which prevents re-initiation and lowers DFT.
Effect of IK,ACh-c blockade in whole-heart electrical cardioversion
As many of the events investigated in the present study may occur subepicardially in the whole heart, our 2D AF model allowed us to obtain unique insights into the mechanisms determining aDFT. However, to confirm the aDFT lowering effect of IK,ACh-c blockade in the more complex and clinically relevant 3D setting, we studied the effect of IK,ACh-c blockade by tertiapin during whole-heart mapping (Fig. 8a). Indeed, using the lowest defibrillation energy (30 V), failed defibrillation was observed in control hearts. Re-initiation of fibrillation was a major mechanism of failed defibrillation, because a notable change in cycle length could be observed after the electrical shock, suggesting that a different reentrant pathway maintained subsequent fibrillation (Fig. 8b). Following tertiapin treatment, hearts displayed a strong increase in atrial APD and cycle length after AF induction (Fig. 8c) and showed termination of AF by ECV at the lowest voltage (30 V). As expected from the in vitro experiments, tertiapin evidently decreased the ECV threshold (36.1 ± 11.3 vs 27.2 ± 0.66 V in untreated control hearts) (Fig. 8d), while the success rate of ECV at 30 V shocks was increased by 60% (100% vs 40% in control hearts) (Fig. 8e). Together, these results support the notion that IK,ACh-c increases ECV threshold and decreases success rate of atrial defibrillation in the whole heart.
Discussion
Key findings of this study are: (1) Pharmacological blockade of IK,ACh-c in neonatal rat aCMC cultures or intact atria exhibiting persistent spiral waves of electrical activity, results in a significant increase in the wavelength of reentry and decrease in the energy required for electrical defibrillation (i.e. a decreases in aDFT). Similar results were obtained after RNAi-mediated downregulation of one of the molecular correlates of IK,ACh-c, Kir 3.4. (2) IK,ACh-c inhibition lowers aDFT by preventing post-shock arrhythmia re-initiation following defibrillation attempts with low voltage shocks. (3) Mechanistically, blockade of IK,ACh-c moderates the spatial shock-induced differences in depolarization and prevents propagation of the shock-induced AP wavefront, through the increase in wavelength. (4) Finally, IK,ACh-c may serve as a target for lowering the energy requirements for ECV and increasing its effectiveness, without altering ventricular electrophysiology, thereby limiting the harmfulness of (pharmacologically assisted) ECV.
AF is known to be a progressive disease; patients with paroxysmal AF therefore often develop persistent or even permanent AF2,3. The underlying principle of AF begetting AF, is one of the reasons for applying cardioversion in AF patients. Moreover, with disease progression, increasing amounts of energy may be required for successful ECV and patients with permanent AF may ultimately become refractory to cardioversion9,10,22. As the success rate of ECV already decreases after 24 h of AF22, this decrease is likely (at least partially) attributable to electrical remodeling (as opposed to its structural counterpart). In this study, we have elaborated on the effect of electrical remodeling on ECV success rate. We show that IK,ACh-c, as a constituent of this remodeling, is a sufficient cause for an increase in aDFT and a decrease in ECV success rate. Since the molecular components of IK,ACh-c are absent in the ventricles, blockade of IK,ACh-c might provide an atrium-specific target to facilitate successful ECV of AF without increasing the risk of ventricular pro-arrhythmia, thereby adding to the significance of our results.
According to present theories, defibrillation will fail if the portion of the myocardium that is excited or rendered refractory by the electrical shock is too small to effectively cause termination of all reentrant conduction23,24. Indeed, the present study confirms that exciting a critical portion of the myocardium is essential for successful defibrillation. If the shock strength is too low to meet this requirement, the consequent incomplete synchronization of the gradual progression of phase around the PS will lead to its continued existence and thereby to ineffective defibrillation. However, we show that close to the DFT, failure of electrical shocks to defibrillate may occur even if their strength is enough to cause elimination of all pre-existing PSs25,26,27. Here, post-shock formation of PSs is the underlying cause of defibrillation failure. Hence, extinguishing the wavefronts that perpetuate fibrillation through synchronous depolarization is necessary but not sufficient for successful defibrillation.
While other studies, mostly focusing on ventricular fibrillation, have postulated re-initiation of fibrillation as an important mechanism of defibrillation failure of electrical shocks near the DFT, controversy remains regarding the origin of post-shock re-initiation. The presence of an isoelectric window after a failed defibrillation shock (i.e. the temporal gap between the application of a shock and the observation of first epicardial activation) was the first clue that led to the introduction of the theories postulating re-initiation of reentry to underlie defibrillation failure27. Because of this gap it has been hypothesized that the re-initiation of (ventricular) fibrillation could be caused by triggered activity resulting from early (EADs) or delayed afterdepolarizations (DADs)28. In the present study post-shock EADs and DADs were not observed. Moreover, APD prolongation was shown to prevent post-shock re-initiation of reentrant activity. If in our case formation of the first PS after the electrical shock would depend on phase-2 EADs, APD prolongation would increase the chance for re-initiation as well as the DFT. However, APD prolongation does decrease the susceptibility for post shock late phase-3 EADs and DADs27. Still, in contrast to our findings, these phenomena are associated with long isoelectric windows or immediate recurrence of AF (IRAF) after primary ECV success29. Our results therefore suggest that afterdepolarizations are an unlikely cause of defibrillation failure in AF. Given the rapid reappearance of fibrillatory electrical activity after unsuccessful ECV (Figs 5 and 8), the isoelectric window in whole hearts could be attributable to intramural reentry occurring before activation becomes measurable at the epicardium.
In theory, the origin of re-initiation could also be the electrical shock itself. Several studies showed that when exposed to external field stimulation, areas of cardiac tissue can be either excited (i.e. the virtual cathode) or de-excited (i.e. the virtual anode)30,31. The latter causes AP shortening, which restores excitability in the de-excited area26,32. As a consequence of electrotonic interaction between the depolarized and the hyperpolarized area (i.e. break excitation)33. new wavefronts can be formed and propagated in the direction of the excitable de-excited area after the shock, potentially creating new reentrant circuits that cause shock failure26,34.
In the present study, de-excitation was far less apparent (although small areas of APD shortening were observed, analogous to virtual anodes). As tissue heterogeneity may be a determinant of the occurrence of virtual electrode polarization35,36, this difference may, in part, be attributed to the homogeneous nature of our cell culture model. More importantly, virtual electrode polarization may be prevented by the use of a biphasic shock, as utilized in our study. The second phase of a biphasic shock is thought to quickly re-excite the de-excited area, while only partially de-exciting the excited area, homogenizing post-shock polarization26. As such, the effectiveness of the biphasic shock in preventing virtual electrode formation depends on the amplitude of the second phase relative to that of the first phase. In the present study, the peak voltage of the second phase was 20% of the maximum voltage in the first phase, which has been previously shown to cause effective asymmetric reversal of the polarity in the first phase, thereby preventing virtual electrode formation26.
Moreover, according to the virtual electrode hypothesis of defibrillation strong shocks can prevent virtual electrode polarization and re-initiation by enlarging the areas of complete de-excitation. If a wavefront is formed by break excitation, this wavefront will promptly excite the de-excited area as a consequence of its local shock-induced gain in excitability. As this fast excitation does not allow for recovery of the virtual cathode area, new reentrant circuits are prevented32. In our model, strong shocks do not increase de-excitation (again as a consequence of its biphasic nature), but increase the amount of excited tissue (that would have been refractory to low shock voltages). As a consequence post-shock polarization is homogenized, which prevents re-initiation. Similarly, tertiapin decreases the steepness in the relationship between the shock-induced AP amplitude and the PPI, which also homogenized post-shock polarization. Simultaneously, tertiapin increases refractoriness in incompletely depolarized areas and hence prevents propagation of wavefronts initiated at depolarized areas, which together decrease DFT. Hence, our paper shows that DFT can be decreased through other means than by increasing de-excitation, in the context of a biphasic shock. Still, mechanisms of re-initiation found in our study are largely analogous to the virtual electrode hypothesis being dependent heterogeneous polarization.
Finally, the critical point hypothesis of defibrillation states that reentry can initiate at critical junctions between the shock-induced extracellular potential gradient and the refractoriness gradient caused by the last pre-shock activation37. The present study confirms that re-initiation of AF depends on local tissue refractoriness. It should be noted, however, that the critical point hypothesis stems from experiments in which a monophasic S2 shock was given during phase 2 or 3 of the AP from a plane perpendicular to that of the S1 shocks, causing potential and refractoriness gradients to cross each other28,37. Applying biphasic shocks during fibrillation, should partly resolve the potential gradient and cause the refractoriness to be dispersed. At variance with the critical point hypothesis, in our model formation of critical points (i.e. post-shock PSs) occurred in the area of highest refractoriness (i.e. the shortest PPI), instead of remote from this area.
The fact that most of the current theories about cardiac fibrillation and defibrillation mechanisms come from the field of ventricular fibrillation and can only partly explain our findings, may also indicate that different mechanisms might be responsible for defibrillation failure in ventricular fibrillation and AF, underlining the novelty of our results.
In this study, we utilized models of AF in which tachyarrhythmic activation after burst pacing relies on reentrant activity. As focal mechanisms may also underlie fast activation during AF38, the energy necessary to eliminate AF of focal origin, as well as the effect of diminishing IK,ACh-c, on the efficiency with which such an arrhythmia can be terminated may be different from what was found in the present study. Still, it should be noted that reentrant re-initiation at critical PPIs can also occur after eliminating a focal source by electrical shock. Hence, in this case a protective effect of IK,ACh-c might be expected. Further studies will be necessary to explore this possibility.
In addition, ECV in the clinical setting not only fails because of true shock failure but also by IRAF in which, after the electrical shock, one or more sinus beats are followed by re-initiation of AF39. Only the true shock failure aspect of ECV failure has been investigated in the present manuscript. Since the mechanisms for true shock failure and IRAF may differ, blockade of IK,ACh-c might not prevent ECV failure due to IRAF. Nonetheless, we and others have shown that IK,ACh-c blockade can also prevent the initiation of AF18,40.
The use of neonatal rat aCMC monolayers allowed us to systematically study the mechanisms of AF in the context of IK,ACh-c inhibition in a controllable environment. These monolayers are, however, inherently different from intact human atria because of their 2D nature and the electrophysiological differences between human and rat aCMCs. Nonetheless, results obtained in our 2D model were reproduced in intact hearts, confirming its relevance. Due to the minute dimensions of the intact neonatal rat heart, crosstalk between the ventricular and atrial optical signal was observed during optical mapping. Still, presence or absence of AF is easily derived from the obtained atrial signal. As a consequence of this crosstalk, no analyses on post-shock reinitiation mechanisms were performed in the whole heart. Hence, we concur that the results of this study are conceptual with respect to ECV in humans and therefore cannot be readily extrapolated to the clinical setting.
Conclusions
This is the first study to systematically study the role of the IK,ACh-c in atrial defibrillation. The results indicate that remodeling of this current, as occurs during AF, can contribute to an increase in aDFT and failure of ECV. Hence, IK,ACh-c may serve as an interesting target for lowering the energy requirements for ECV and increasing its effectiveness, without altering ventricular electrophysiology, limiting the harmfulness of (pharmacologically assisted) ECV.
Methods
A detailed description of materials and methods can be found in the Supplementary Material online.
All animal experiments were approved by the Animal Experiments Committee of the Leiden University Medical Center and conformed to the Guide for the Care and Use of Laboratory Animals as stated by the US National Institutes of Health.
Preparation of aCMC monolayers
Neonatal rat aCMCs were isolated by collagenase digestion and cultured on 15-mm-diameter fibronectin-coated coverslips as described previously18. A cell density of 8 × 105 cells/well in 24-well culture plates was maintained throughout the experiments by restricting proliferation (of non-myocytes) through treatment with Mitomycin-C (Sigma-Aldrich, St. Louis, MO) at day 1 of culture.
RNAi
Self-inactivating lentiviral vectors encoding enhanced green fluorescent protein (eGFP) and a shRNA specific for rat Kcnj5 (LV-Kir3.4↓) or for Photinus pyralis luciferase (LV-PpLuc↓, negative control vector) were generated as described in detail in the Supplementary Material online. Transduction was performed at day 4 of culture. Knockdown of Kir3.4 after transduction with LV-Kir3.4↓ was confirmed using Western blot.
Optical mapping
High resolution optical mapping was performed at day 9 of culture using di-4-ANEPPS (Life Technologies) as a voltage-sensitive dye and a MiCAM ULTIMA-L imaging system (SciMedia, Costa Mesa, CA) as described previously18. For 1-Hz or burst pacing of confluent aCMC cultures (Fig. 1a), a custom epoxy-coated bipolar electrode was used, resulting in normal convex waves (Fig. 1b, left picture) or reentrant spiral waves (Fig. 1b, right picture), respectively. Defibrillation was performed using a custom electroshock module (Supplemental Fig. 1A), which was coupled to two platinum electrodes fixed in a plastic ring that was readily mountable to the top of a 24-well culture plate. Electrodes were 9-mm in length, placed parallel 11-mm apart and 2 mm above the surface of the culture (Supplemental Fig. 1B–D). This setup produced biphasic truncated exponential shocks of adjustable voltages (≈25–105 V) with the second-phase peak voltage being 20% of the first-phase peak voltage (Fig. 1C). DFT was defined as the voltage used during the first shock (starting from ≈25 V and progressively increasing with 10-V increments) leading to full elimination of arrhythmic activity.
To assess the effect of IK,ACh-c blockade on defibrillation, tertiapin (100 nM) was pipetted in the medium and dispersed by gentle agitation, directly followed by optical mapping.
Whole heart di-4-ANEPPS-mapping was performed on neonatal rat hearts suspended in a 16-mm diameter tissue bath. Hearts were perfused with oxygenated Tyrode’s solution (comprising [in mM] NaCl 130, CaCl2 1.8, KCl 4.0, MgCl2 1.0, NaH2PO4 1.2, NaHCO3 24 and glucose 5.5 at pH 7.4) supplemented with 20 mM 2,3-butanedione monoxime (Sigma-Aldrich) to minimize motion artifacts. The burst pacing, electrical shock protocol and electrode setup (mounted to the tissue bath) used to determine the aDFT were equal to those used in the in vitro experiments.
Statistics
Statistical analyses and construction of corresponding graphs were performed using Graphpad Prism 6.0 (Graphpad Software, San Diego, CA). Comparison between two groups was performed using the non-parametric Mann-Whitney U test (for unpaired measurements) or Wilcoxon signed rank (for paired measurements) test. Kruskall-Wallis testing with Bonferoni post-hoc correction was used for multiple groups and comparisons. Data were expressed as mean ± standard deviation (SD) for a number (n) of observations. Differences were considered statistically significant if p < 0.05. Non-linear regression curves were constructed by using a robust exponential two-phase decay curve fit. Accuracy of these curves was expressed as the coefficient of determination (R2).
Additional Information
How to cite this article: Bingen, B. O. et al. Constitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defibrillation Threshold by Favoring Post-Shock Re-Initiation. Sci. Rep. 5, 15187; doi: 10.1038/srep15187 (2015).
References
Lloyd-Jones, D. M. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 110, 1042–1046 (2004).
Nieuwlaat, R. et al. Prognosis, disease progression and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J. 29, 1181–1189 (2008).
Wijffels, M. C., Kirchhof, C. J., Dorland, R. & Allessie, M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 92. 1954–1968 (1995).
Benjamin, E. J. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 98, 946–952 (1998).
Shinbane, J. S. et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 29, 709–715 (1997).
Wolf, P. A., Abbott, R. D. & Kannel, W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 22, 983–988 (1991).
Anderson, J. L. et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 61, 1935–1944 (2013).
Chugh, S. S., Blackshear, J. L., Shen, W. K., Hammill, S. C. & Gersh, B. J. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 37, 371–378 (2001).
Mittal, S. et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 101, 1282–1287 (2000).
Van Gelder, I. C., Crijns, H. J., van Gilst, W. H., Verwer, R. & Lie, K. I. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 68, 41–46 (1991).
Blich, M. & Edoute, Y. Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate. Int J Cardiol. 107, 389–394 (2006).
Ambler, J. J. & Deakin, C. D. A randomised controlled trial of the effect of biphasic or monophasic waveform on the incidence and severity of cutaneous burns following external direct current cardioversion. Resuscitation. 71, 293–300 (2006).
Page, R. L. et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 39, 1956–1963 (2002).
Cha, T. J. et al. Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation. 113, 1730–1737 (2006).
Dobrev, D. et al. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res. 54, 397–404 (2000).
Dobrev, D. et al. The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation. 112, 3697–3706 (2005).
Ehrlich, J. R. et al. Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium. J Physiol. 557, 583–597 (2004).
Bingen, B. O. et al. Atrium-Specific Kir3.x Determines Inducibility, Dynamics and Termination of Fibrillation by Regulating Restitution-Driven Alternans. Circulation. 128, 2732–2744 (2013).
Echt, D. S. et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 324, 781–788 (1991).
Hohnloser, S. H., & Singh, B. N. Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors and clinical implications. J Cardiovasc Electrophysiol. 6, 920–936 (1995).
Clayton, R. H., Zhuchkova, E. A. & Panfilov, A. V. Phase singularities and filaments: simplifying complexity in computational models of ventricular fibrillation. Prog Biophys Mol Biol. 90, 378–398 (2006).
Ricard, P. et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol. 79, 815–816 (1997).
Dosdall, D. J., Fast, V. G. & Ideker, R. E. Mechanisms of defibrillation. Annu Rev Biomed Eng. 12, 233–258 (2010).
Zipes, D. P., Fischer, J., King, R. M., Nicoll, A. D. & Jolly, W. W. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol. 36, 37–44 (1975).
Chen, P. S. et al. Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. J Clin Invest. 77, 810–823 (1986).
Efimov, I. R., Cheng, Y., Van Wagoner, D. R., Mazgalev, T. & Tchou, P. J. Virtual electrode-induced phase singularity: a basic mechanism of defibrillation failure. Circ Res. 82, 918–925 (1998).
Wang, N. C. et al. Optical mapping of ventricular defibrillation in isolated swine right ventricles: demonstration of a postshock isoelectric window after near-threshold defibrillation shocks. Circulation. 104, 227–233 (2001).
Chattipakorn, N. & Ideker, R. E. Delayed afterdepolarization inhibitor: a potential pharmacologic intervention to improve defibrillation efficacy. J Cardiovasc Electrophysiol. 14, 72–75 (2003).
Burashnikov, A. & Antzelevitch, C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation. 107, 2355–2360 (2003).
Sobie, A., Susil, R. C. & Tung, L. A generalized activating function for predicting virtual electrodes in cardiac tissue. Biophys J. 73, 1410–1423 (1997).
Wikswo, J. P., Lin, S. F. & Abbas, R. A. Virtual electrodes in cardiac tissue: a common mechanism for anodal and cathodal stimulation. Biophys J. 69, 2195–2210 (1995).
Cheng, Y., Mowrey, K. A., Van Wagoner, D. R., Tchou, P. J. & Efimov, I. R. Virtual electrode-induced reexcitation: A mechanism of defibrillation. Circ Res. 85, 1056–1066 (1999).
Skouibine, K. B., Trayanova, N. A. & Moore, P. K. Anode/cathode make and break phenomena in a model of defibrillation. IEEE Trans Biomed Eng 46, 769–777 (1999).
Hillebrenner, M. G., Eason, J. C. & Trayanova, N. A. Mechanistic inquiry into decrease in probability of defibrillation success with increase in complexity of preshock reentrant activity. Am J Physiol Heart Circ Physiol. 286, H909–H917 (2004).
Fast, V. G., Rohr, S., Gillis, A. M. & Kleber, A. G. Activation of cardiac tissue by extracellular electrical shocks: formation of ‘secondary sources’ at intercellular clefts in monolayers of cultured myocytes. Circ Res. 82, 375–385 (1998).
Trayanova, N., Skouibine, K. & Aguel, F. The role of cardiac tissue structure in defibrillation. Chaos. 8, 221–233 (1998).
Frazier, D. W. et al. Stimulus-induced critical point. Mechanism for electrical initiation of reentry in normal canine myocardium. J Clin Invest. 83, 1039–1052 (1989).
Jalife, J. Deja vu in the theories of atrial fibrillation dynamics. Cardiovasc Res. 89, 766–775 (2011).
Rossi, M., & Lown, B. The use of quinidine in cardioversion. Am J Cardiol. 19, 234–238 (1967).
Yamamoto, W. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs. J Cardiovasc Pharmacol. 63, 421–427 (2014).
Acknowledgements
We thank Sander van Berloo and Huybert van der Stadt for excellent technical support and Dirk Ypey for instructive discussions. We thank Martin Schalij for commenting on the manuscript. This study was supported by the Dutch Heart Foundation (E. Dekker grant [2012/T023 to B.O.B.]) and the Netherlands Organization for Scientific Research (Veni grant [91611070 to D.A.P.]).
Author information
Authors and Affiliations
Contributions
B.O.B. conceived and designed the study, performed experiments, analyzed and interpreted data and prepared the manuscript and figures. S.F.A. analyzed data, supervised experiments and prepared the manuscript. Z.N. and I.F. constructed the SIN-LV shuttle plasmids and produced LV vectors. A.P. analyzed and interpreted data and prepared the manuscript. A.A.F.d.V. designed LV vectors, supervised LV vector production and designed the study. D.A.P. supervised design, experiments, analyses and preparation of manuscript and figures. All authors commented on and approved the final version of the manuscript.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Electronic supplementary material
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Bingen, B., Askar, S., Neshati, Z. et al. Constitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defibrillation Threshold by Favoring Post-Shock Re-Initiation. Sci Rep 5, 15187 (2015). https://doi.org/10.1038/srep15187
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep15187
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.